Novel cytotoxic agents from an unexpected source: Bile acids and ovarian tumor apoptosis

Gynecologic Oncology

Volumn 107, Issue 2, 2007, Pages 344-349

  Horowitz, Neil S ^a   Hua, Jun ^b   Powell, Matthew A ^b   Gibb, Randall K ^b   Mutch, David G ^b   Herzog, Thomas J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Bile salts; MTT assay; Ovarian cancer

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; CISPLATIN; DEOXYCHOLIC ACID; PROTEIN KINASE C; URSODEOXYCHOLIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NUCLEOSOME; OVARY TUMOR; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BILE ACIDS AND SALTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHENODEOXYCHOLIC ACID; CHOLIC ACID; COLORING AGENTS; DEOXYCHOLIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; NUCLEOSOMES; OVARIAN NEOPLASMS; PROTEIN KINASE C; TETRAZOLIUM SALTS; THIAZOLES; URSODEOXYCHOLIC ACID;

EID: 35348902173     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.07.072     Document Type: Article

References (21)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 1 (Jan-Feb 2007) 43-66
2. Bristow R.E., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian cancer during the platinum era: a meta-analysis. J Clin Oncol 20 5 (2002) 1248-1259
3. McGuire W.P., et al. Cyclophosphamide and cisplatin compared to paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334 1 (1996) 1-6
4. Ozols R.F., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 17 (2003) 3194-31200
5. Armstrong B., and Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practice. Int J Cancer 15 (1975) 617-631
6. Reddy B.S., and Wynder E.L. Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. JNCI 50 (1973) 1437-1442
7. Kandell R.L., and Bernstein C. Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutr Cancer 16 (1991) 227-238
8. Morvay K., Szentleleki K., Torok G., Pinter A., Borzsonyi M., et al. Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats. Dis Colon Rectum 32 (1989) 860-863
9. Cohen B.I., Raicht R.F., Deschner E.E., Takahashi M., Sarwal A.N., et al. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. JNCI 64 (1980) 573-578
10. Martinez J.D., Stratagoules E.D., LaRue J.M., Powell A.A., Gause P.R., Craven M.T., et al. Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31 2 (1998) 111-118
11. Milovic V., Teller I.C., Faust D., Caspary W.F., and Stein J. Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Investig 32 (2002) 29-34
12. Markman M. Viewing ovarian cancer as a "chronic disease": what exactly does this mean?. Gynecol Oncol 100 2 (2006) 229-230
13. Kuo M.T., Chen H.H., Song I.S., Savaraj N., and Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev (Feb 23 2007)
14. Meijer C., Mulder N.H., Timmer-Bosscha H., Sluiter W.J., Meersma G.J., and de Vries E.G. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res 52 24 (1992) 6885-6889
15. Yang X., Zheng F., Xing H., Gao Q., Wei W., Lu Y., et al. Resistance to chemotherapy induced apoptosis via decreased caspase-3 activity and overexpression of anti-apoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol 130 7 (2004) 423-428
16. Im E., Choi S.H., Suh H., Choi Y.H., Yoo Y.H., and Kim N.D. Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-κB dependent process in human cervical carcinoma cells. Cancer Lett 229 (2005) 49-57
17. Choi Y.H., Im E.O., Suh H., Jin Y., Yoo Y.H., and Kim N.D. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett 199 (2003) 157-167
18. Suh H., Jung E.J., Kim T.H., Lee H.Y., Park Y.H., and Kim K.W. Anti-angiogenic activity of ursodeoxycholic acid and its derivatives. Cancer Lett 113 1-2 (1997) 117-122
19. Seo S.Y., Jun E.J., Jung S.M., Kim K.H., Lim Y.J., Park B.S., et al. Synthetic chenodeoxycholic acid derivative HS-1200 induced apoptosis of p815 mastocytoma cells is augmented by co treatment with lactacystin. Anticancer Drugs 14 3 (2003) 219-225
20. Guarino M.P., Carott S., Sarzano M., Alloni R., Vanni M., Grosso M., et al. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial. Neurogastroententerol Motil 17 5 (2005) 680-686
21. Einarsson C., Hillebrant C.G., and Axelson M. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on hepatic synthesis of cholesterol and bile acids in healthy subjects. Hepatology 33 5 (2001) 1189-1193